Tryp Therapeutics Inc (TRYP.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 11-2023 | 08-2023 | 05-2023 | 02-2023 | 11-2022 | |
| Operating Expenses | 951 | 1,071 | 771 | 1,266 | 1,616 |
| Operating Income | -951 | -1,071 | -771 | -1,266 | -1,616 |
| Interest Expense | N/A | N/A | 58 | N/A | N/A |
| Other Income | -210 | -491 | 46 | -21 | -18 |
| Pre-tax Income | -1,161 | -1,562 | -784 | -1,287 | -1,634 |
| Income Tax | N/A | N/A | -128 | N/A | N/A |
| Net Income Continuous | -1,161 | -1,690 | -656 | -1,287 | -1,634 |
| Net Income | $-1,161 | $-1,690 | $-656 | $-1,287 | $-1,634 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EBITDA(a) | $-951 | $-1,078 | $-726 | $-1,266 | $-1,616 |